Sterling Capital Management’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35K Sell
327
-230
-41% -$1.01K ﹤0.01% 3084
2026
Q1
$2.01K Sell
557
-385
-41% -$1.33K ﹤0.01% 2996
2025
Q4
$3.21K Buy
942
+107
+13% +$519 ﹤0.01% 2996
2025
Q3
$5.67K Buy
835
+476
+133% +$3.93K ﹤0.01% 2734
2025
Q2
$4.89K Buy
359
+98
+38% +$925 ﹤0.01% 2533
2025
Q1
$1.42K Sell
261
-209
-44% -$1.19K ﹤0.01% 2698
2024
Q4
$2.33K Buy
470
+406
+634% +$2.13K ﹤0.01% 2744
2024
Q3
$335 Buy
+64
New +$369 ﹤0.01% 3006

Other funds holding LFMD

Sterling Capital Management's LFMD Position: Q2 2026 in Review

Sterling Capital Management reduced its LifeMD (LFMD) stake by 41% in Q2 2026, selling an estimated $1.01K and leaving 327 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #3084.

Sterling Capital Management first reported a position in LFMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.67K in Q3 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Sterling Capital Management held 327 shares of LifeMD worth $1.35K as of Q2 2026.
  • Sterling Capital Management sold 230 LifeMD shares in Q2 2026, an estimated $1.01K.
  • LifeMD made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3084 holding.
  • Sterling Capital Management first reported a position in LifeMD in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's LifeMD position peaked at $5.67K in Q3 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.